Since overexpression and aberrant activation of EGFR and its downstream signaling pathways is inhibited by delphinidin, we next examined its effect on the cellular proliferation of NSCLC cells by employing an MTT assay. Here, EGFR is linked to non-small cell lung carcinoma.